The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice
about
Urokinase receptor and resistance to targeted anticancer agentsStructure-based Engineering of Species Selectivity in the Interaction between Urokinase and Its Receptor: IMPLICATION FOR PRECLINICAL CANCER THERAPYuPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling.uPAR induces expression of transforming growth factor β and interleukin-4 in cancer cells to promote tumor-permissive conditioning of macrophages.The time course of resolution of adhesions during fibrinolytic therapy in tetracycline-induced pleural injury in rabbits.Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin β1/FAK signaling in medulloblastoma.The urokinase receptor supports tumorigenesis of human malignant pleural mesothelioma cells.Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cellsIn vivo anti-metastatic effects of uPAR retargeted measles virus in syngeneic and xenograft models of mammary cancerCrosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells.Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is enhanced in irradiated medulloblastoma cells.A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogenProtein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude miceReversibility of epithelial-mesenchymal transition (EMT) induced in breast cancer cells by activation of urokinase receptor-dependent cell signaling.Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer.Selection of a Novel Aptamer Against Vitronectin Using Capillary Electrophoresis and Next Generation Sequencing.SCA-1 Labels a Subset of Estrogen-Responsive Bipotential Repopulating Cells within the CD24+ CD49fhi Mammary Stem Cell-Enriched Compartment.Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer.Molecular Effects of Stromal-Selective Targeting by uPAR-Retargeted Oncolytic Virus in Breast Cancer.Urokinase is a negative modulator of Egf-dependent proliferation and motility in the two breast cancer cell lines MCF-7 and MDA-MB-231.Targeting of peptide conjugated magnetic nanoparticles to urokinase plasminogen activator receptor (uPAR) expressing cells.Transforming growth factor-β, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition.Urinary-type plasminogen activator receptor (uPAR) modulates oral cancer cell behavior with alteration in p130cas.Snail mediates invasion through uPA/uPAR and the MAPK signaling pathway in prostate cancer cellsA cleavage-resistant urokinase plasminogen activator receptor exhibits dysregulated cell-surface clearance.Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models.Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors.Hypothesis about Transdifferentiation As Backbone of Malignancy.D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.The Urokinase Receptor Induces a Mesenchymal Gene Expression Signature in Glioblastoma Cells and Promotes Tumor Cell Survival in Neurospheres.Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits.N-Formyl Peptide Receptors Induce Radical Oxygen Production in Fibroblasts Derived From Systemic Sclerosis by Interacting With a Cleaved Form of Urokinase Receptor.
P2860
Q26797385-2F43364A-FC28-4161-984E-B47B2C06958CQ27659603-27281FF2-5DDF-4F62-81F6-AED4C9A49079Q30249137-68C2F6C8-2446-43B7-895E-541A3A5A6577Q30361219-FF9841F2-C18D-496A-8F46-6B30250472E2Q30365899-B6674069-8200-4F8C-B70B-116F785DDEB9Q30374418-74B01FD7-B657-415D-99CB-DDAF3BB70AF4Q33707627-3A735551-60E1-4175-9DC9-B43865571B4CQ33938369-055F2884-D621-4FD1-814C-EA0FC571DD38Q34267846-4C23F9BC-7D1F-4D8F-9ECD-32E0ABB6F2C5Q34997475-029330E0-37F1-4EDE-877B-F3C90D7D2A6FQ35229306-073AE18D-097E-4C69-996E-F72F2DE1A854Q36016967-A4F80C9A-C119-402C-A021-0BCA0B188A12Q36059078-3BF399E3-DAE0-48C6-8D93-3AED711B016DQ36289925-63E478A0-1B41-41A4-B7F4-186401ED23AFQ37371663-DF75A013-77C4-4429-A370-B1900E4C42EFQ37432551-3042188A-C560-4917-A0CD-FC90C7A619C5Q37501585-D42883F0-EE01-40B3-B792-A69DCB8F6F00Q37644732-DCC7B28B-5703-4633-87C4-F5037F4AD619Q38132176-2232100F-8560-4E66-AFA9-B47489FE51C2Q38692304-D1D2CCA9-441D-4A30-AE97-0B5E4E2C69ABQ38914216-AB6EF56C-5843-4733-8E80-DB0010DD43CDQ39128849-89C67FC4-7C0A-4704-A23B-FD0ECFB826CCQ39443785-5CC82669-3B2B-4941-A244-69BE9CF3EC5BQ39532629-D111797A-FBCE-4075-A1AC-AFF7F7AF7A0CQ39988571-CFCAF459-2671-421A-963B-367BF7806481Q40105822-2FB98E40-587F-431A-BF54-609D958C3EF8Q40637119-DFCD0F03-0DA9-47D7-BF4D-34EFEA385C28Q41518094-5A1C7D97-91C8-4AFF-8E48-C20C47ABD91BQ42152209-1075348F-15B2-4617-A91D-8A6CEE9ACC45Q48220228-95F7E65E-352E-4037-8BFC-7A643F29F8C9Q50201202-7C26FFAE-5374-426F-9394-58C2E3BB4ECBQ50241255-35AA04A1-7081-4A45-A6E0-066744C4819FQ52718407-C03756F2-9D2C-4A39-AFAD-9504505C93E2
P2860
The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The urokinase receptor promote ...... plasminogen activator in mice
@en
The urokinase receptor promote ...... plasminogen activator in mice.
@nl
type
label
The urokinase receptor promote ...... plasminogen activator in mice
@en
The urokinase receptor promote ...... plasminogen activator in mice.
@nl
prefLabel
The urokinase receptor promote ...... plasminogen activator in mice
@en
The urokinase receptor promote ...... plasminogen activator in mice.
@nl
P2093
P2860
P1476
The urokinase receptor promote ...... plasminogen activator in mice
@en
P2093
Shinako Takimoto
Steven L Gonias
Valerie Montel
P2860
P304
P356
10.2353/AJPATH.2009.081053
P407
P577
2009-06-04T00:00:00Z